Technology Entrepreneurship

course participant listening

Course Features

Do you have the next big technology break through?

In the Technology Entrepreneurship course, explore the intersection of innovation, technology, and business, gain the insights to bring a new venture to market, and finally, pitch your idea to a panel of venture capitalists.

Designed for innovators in any field or ready to break into any field, learn the fundamentals of the venture creation process, reinforce those lessons by testing the viability of your own ideas, and bring technology ideas to market.

Johns Hopkins world-class faculty will lead you through the necessary steps to make a successful pitch. Then leverage the experience of experienced business mentors, participate in engaging course discussions, and take on experiential projects to full develop your idea. The course culminates in the pitch of your products or services to a panel of venture capitalists, industry experts, and experienced entrepreneurs.

All courses include:

  • Industry-leading faculty
  • Collaborative learning
  • Research-driven results
  • Lifelong connections
  • Practical applications
  • Custom solutions

Program Details

Who should attend

This course is customized for corporate venture officers, startups, those who would like to develop or strengthen entrepreneurship in their corporation, and aspiring entrepreneurs interested in starting their own company from a technology product or service idea. Teams of entrepreneurs are encouraged to participate together or individually.

What you will learn

  • Create a new product or service idea
  • Evaluate the feasibility of product or service idea in the market
  • Develop a pitch to communicate the product or service idea



Supriya Munshaw, PhD

Senior Lecturer, Carey Business School

Supriya Munshaw, PhD (Computational Biology & Bioinformatics, Duke University) joined the Carey Business School faculty in 2013. She is a senior lecturer in the practice track with interest in technology transfer and commercialization of early-stage technologies. At Carey Business School, she has taught several courses including Discovery to Market, Biotechnology and Pharmaceuticals, Statistical Analysis, Business Leadership and Human Values, and New Product Development.

Phillip Phan

Phillip Phan, PhD

Alonzo And Virginia Decker Professor of Strategy And Entrepreneurship

Phillip Phan is Alonzo and Virginia Decker Professor at the Johns Hopkins Carey Business School with joint appointments in the Johns Hopkins Medicine Department of Medicine, Whiting School of Engineering Malone Center for Engineering in Healthcare, and the Johns Hopkins Armstrong Institute for Patient Safety and Quality.  He is Associate Director at the Johns Hopkins Medicine Institute for Clinical and Translational Research. 

Ning Li

Ning Li, PhD

Associate Professor, Carey Business School

Ning Li is an Associate Professor at the Johns Hopkins Carey Business School. Her research interests include business-to-business marketing strategy, global marketing strategy, and marketing ethics. She has taught both online and onsite courses to MBA, MS, EMBA, and undergraduate students.

Robert Mislavsky

Robert Mislavsky, PhD

Assistant Professor, Carey Business School

Rob Mislavskyis an Assistant Professor on the research track. He joined Carey in 2018. His research primarily focuses on how consumers form preferences and evaluate uncertainty.


Christopher E. Jeffers, PhD

Executive Education Faculty, Carey Business School

Chris is a 25+ year veteran of healthcare and biotech. Chris began his career running clinical laboratories for the U.S. Air Force and civilian hospitals in the early 90’s. Since then, he has held various roles, including CEO, General Counsel, Vice President of Drug Discovery, Investor, Managing Director and has served as outside counsel to hundreds of life science companies ranging from big pharma to individual inventors. Prior to joining Mintz and ML Strategies, Chris was an intellectual property litigator where he specialized in representing life science companies in complex intellectual property litigation, including ANDA litigation.